![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Otsuka Can Block Generic Abilify as Court Rejects Appeal
Otsuka Can Block Generic Abilify as Court Rejects Appeal
January 15, 2013
The U.S. Supreme Court left intact a ruling that lets Otsuka Holdings (4578)’s pharmaceutical unit block generic competition to its schizophrenia drug Abilify in the U.S. until April 2015.
Bloomberg
Bloomberg
Upcoming Events
-
21Oct